RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 10.65

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-22 )

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.50% 31% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.50% 31% F 9% A-
Trailing 12 Months  
Capital Gain 3.60% 98% N/A 47% F
Dividend Return 4.06% 79% B- 61% D-
Total Return 7.66% 98% N/A 47% F
Trailing 5 Years  
Capital Gain -69.45% 69% C- 6% D-
Dividend Return 2.61% 68% D+ 7% C-
Total Return -66.84% 69% C- 5% F
Average Annual (5 Year Horizon)  
Capital Gain 64.30% 40% F 95% A
Dividend Return 65.62% 40% F 95% A
Total Return 1.32% 60% D- 31% F
Risk Return Profile  
Volatility (Standard Deviation) 433.52% 62% D 3% F
Risk Adjusted Return 15.14% 49% F 30% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.